Cancer biology is a rapidly evolving field, with pathology and biomarker research at the forefront of innovations in ...

The key alterations sought are FGFR3 activating mutations or fusions/rearrangements (“susceptible” alterations), for potential use of the FGFR inhibitor erdafitinib (Balversa), and HER2 IHC expression ...

Panakeia publishes landmark clinical validation showing AI can deliver rapid molecular profiling for colorectal cancerLargest real-world, ...

BERKELEY, Calif. and MAINZ, Germany, June 10, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the ...

A four-biomarker blood panel of aminopeptidase N (ANPEP), polymeric immunoglobulin receptor (PIGR), CA19-9, and ...

The programme will focus on pancreatic, ovarian and oesophageal cancers – three indications that often spread silently.

Early detection and prevention of cancer can save lives, but current tools often fall short because of suboptimal accuracy and limited accessibility. The Fred Hutch Cancer Center aims to change that ...

The proposed cancer screening test is a multi-step process designed to detect tumors in their earliest stages. Patients will swallow a bioengineered pill embedded with tumor sensors that respond to ...

SEATTLE — July 1, 2025 — Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news. Founded in 1975, the Oral Medicine Service at Fred Hutch was the ...

As part of a $93 million grant package, the Cancer Prevention and Research Institute of Texas, known for funding groundbreaking projects, has awarded the University of Houston $3 million to set up a ...

Cancer innovation is advancing at unprecedented speed, but Belgium’s access systems are struggling to keep up, risking delays ...